NCT01351103 2025-06-13A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsNovartisPhase 1 Completed185 enrolled
NCT02278133 2017-10-09Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsArray BioPharmaPhase 1/2 Completed20 enrolled
NCT02649530 2016-09-30A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaUniversity of Michigan Rogel Cancer CenterPhase 2 Withdrawn